This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Celgene Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Robert Plenge
Introduction
Robert Plenge is a notable inventor based in Wellesley, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of combination therapies. His work focuses on innovative methods to treat diseases responsive to the inhibition of PDE4.
Latest Patents
Robert Plenge holds 1 patent for his invention titled "Combination therapies comprising apremilast and Tyk2 inhibitors." This patent outlines methods of treating diseases and disorders by administering apremilast alongside a Tyk2 inhibitor to a subject. Additionally, it includes pharmaceutical compositions that combine these two components for effective treatment.
Career Highlights
Plenge is associated with Celgene Corporation, a leading biopharmaceutical company known for its focus on innovative therapies. His role at Celgene has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Robert has collaborated with esteemed colleagues such as Peter Henry Schafer and Mary Adams. These partnerships have fostered an environment of innovation and have led to advancements in therapeutic strategies.
Conclusion
Robert Plenge's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in combination therapies, highlight the importance of collaboration and research in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile